Biohaven Reports Dosing of First Subject in Pharmacokinetic and Safety Trial of BHV-4157
NEW HAVEN, CT--(Marketwired - July 20, 2016) - Biohaven Pharmaceutical Holding Company Ltd. ("Biohaven" or the "Company") reported today that the Company has begun dosing subjects in its first clinical trial to evaluate the safety and …